Published in Clin Genet on April 09, 2012
Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.93
Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process. Eur J Hum Genet (2013) 1.61
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.31
Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet Med (2014) 1.09
Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics. Hum Mutat (2013) 1.04
Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet (2015) 1.00
Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clin Genet (2013) 1.00
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet (2012) 0.96
Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012. Mol Syndromol (2012) 0.90
Funding considerations for the disclosure of genetic incidental findings in biobank research. Clin Genet (2013) 0.87
Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine. Urol Oncol (2014) 0.86
Emerging issues in paediatric health research consent forms in Canada: working towards best practices. BMC Med Ethics (2013) 0.83
Understanding patient and provider perceptions and expectations of genomic medicine. J Surg Oncol (2014) 0.78
To disclose, or not to disclose? Context matters. Eur J Hum Genet (2014) 0.76
Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J (2007) 2.71
Strategies for consulting with the community: the cases of four large-scale genetic databases. Sci Eng Ethics (2004) 2.47
[Arguments for offering triple test serum screening for Down's syndrome to all pregnant women]. Ned Tijdschr Geneeskd (2002) 2.03
The Public Population Project in Genomics (P3G): a proof of concept? Eur J Hum Genet (2008) 2.03
Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Public Health Genomics (2009) 1.62
Bioethics for clinicians: 14. Ethics and genetics in medicine. CMAJ (1998) 1.61
Research and stored tissues. Persons as sources, samples as persons? JAMA (1995) 1.48
[Genetic cancer syndromes and reproductive choice: dialogue between parents and politicians on preimplantation genetic diagnosis]. Ned Tijdschr Geneeskd (2008) 1.43
[Pregnancy at a later age with the help of oocyte donation]. Ned Tijdschr Geneeskd (2006) 1.38
Human genetic research, DNA banking and consent: a question of 'form'? Clin Genet (2001) 1.09
Raw data: research and health care goals differ. Science (2014) 0.96
Funding considerations for the disclosure of genetic incidental findings in biobank research. Clin Genet (2013) 0.87
Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry. Public Health Genomics (2014) 0.86
Unesco and population genetics. Nature (1996) 0.84
Genetic technologies, health care policy and the patent bargain. Clin Genet (2003) 0.84
Physicians and genetic malpractice. Med Law (2002) 0.83
From community genetics to public health genomics - what's in a name? Public Health Genomics (2008) 0.82
Call for prudence in whole-genome testing. Science (2013) 0.81
Multidisciplinary perceptions of human genetics in Canada: "Delphi" results with regards to the practice of medical genetics. Health Law J (1995) 0.81
Stored tissue samples: through the confidentiality maze. Pharmacogenomics J (2005) 0.81
Public Health Genomics journal: adjusting the agenda to future needs. Public Health Genomics (2011) 0.80
DNA sampling and informed consent. CMAJ (1991) 0.79
Genetic testing, legal capacity and adolescents. Health Law J (1998) 0.77
Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections. Hum Reprod Update (2013) 0.76
Shared lesbian motherhood: a challenge of established concepts and frameworks. Hum Reprod (2010) 0.75
Genetic information and the law: constraints, liability and rights. CMAJ (1986) 0.75
Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands. Clin Genet (2012) 0.75
HUGO's midlife crisis: life begins at 40. Nat Genet (1998) 0.75
International bioethics, human genetics, and normativity. Houst Law Rev (1997) 0.75
Genetics and Society Project. Community Genet (2000) 0.75
Legal liability and the uncertain nature of risk prediction: the case of breast cancer risk prediction models. Public Health Genomics (2012) 0.75
Genetic predisposition to cancer--issues to consider. Semin Cancer Biol (1996) 0.75
Legal regulation of cancer surveillance: Canadian and international perspectives. Health Law J (2000) 0.75
Haemophilia gene therapy: the patients' perspective. Haemophilia (2009) 0.75
[Making embryos for research: first prohibited, now allowed?] Ned Tijdschr Geneeskd (2016) 0.75
[Foetal therapy for Down syndrome: a pro-active ethical reflection]. Ned Tijdschr Geneeskd (2016) 0.75
Ethical decision-making by hospital committees. Can Med Assoc J (1984) 0.75
Ethical issues involved in establishing a registry for familial Alzheimer's disease. Alzheimer Dis Assoc Disord (1994) 0.75
[Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction?] Ned Tijdschr Geneeskd (2017) 0.75
[Medicinal management of pain and symptoms following the withdrawal of treatment in babies and children]. Ned Tijdschr Geneeskd (2008) 0.75